Juvenile and juvenile-onset systemic lupus erythematosus patients: Clinical characteristics, disease activity and damage
Rasha E. Gheith,Iman I. El-Gazzar,Hussein S. El Fishawy,Abeer M. Nour El-Din,Dina M. Rasheed Bahgat,Tamer A. Gheita +5 more
Reads0
Chats0
TLDR
Differences in clinical phenotype has been confirmed, between JSLE and JO-SLE especially as regards serositis, nephritis and heamatological affection and the disease damage was comparable which denotes that the maximum organ involvement occurs in childhood with an almost stationary course.About:
This article is published in Egyptian Pediatric Association Gazette.The article was published on 2017-07-01 and is currently open access. It has received 6 citations till now. The article focuses on the topics: Anti-SSA/Ro autoantibodies & Serositis.read more
Citations
More filters
Journal ArticleDOI
Systemic lupus erythematosus
Lidia Maroñas Jiménez,Carlota Gutiérrez García-Rodrigo,Rafael Muley Alonso,Aurora Guerra Tapia +3 more
Journal ArticleDOI
Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus
Mohammad-Amin Khajezadeh,Gholamreza Zamani,Bobak Moazzami,Zahra Nagahi,Mahdie Mousavi-Torshizi,Vahid Ziaee +5 more
TL;DR: The presence of headache, mood disorders, psychosis, depression, and other neuropsychological manifestations in a patient with JSLE should prompt investigations into diagnosis of the primary nervous system involvement in order to reduce mortality and morbidity.
Journal ArticleDOI
Clinical features, disease activity and outcomes of Malaysian children with paediatric systemic lupus erythematosus: A cohort from a tertiary centre:
TL;DR: Despite high disease activity at diagnosis, the majority had good sustained response to treatment with low overall mortality, however, there was progressive accrual of organ damage, highlighting the need for further research and refinements into therapies for paediatric systemic lupus erythematosus.
Journal ArticleDOI
Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
TL;DR: IL-34 could be a probable marker for J-Sle disease activity which is more aggressive than adult-SLE, and IL-34 blockage may suppress the expression of proinflammatory cytokines in patients’ blood.
Journal ArticleDOI
A Preliminary Predictive Model for Proliferative Lupus Nephritis in Juvenile Systemic Lupus Erythematosus
TL;DR: In this article , a clinical predictive machine learning model using routine standard parameters as an alternative tool to evaluate the probability of proliferative lupus nephritis (ISN/RPS Class III or IV) was developed.
References
More filters
Journal ArticleDOI
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.
TL;DR: The development of the SLEDAI is described, a validated model of experienced clinicians' global assessments of disease activity in lupus, which represents the consensus of a group of experts in the field of l upus research.
Journal ArticleDOI
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri,Ana Maria Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,Paul R. Fortin,Ian N. Bruce,David A. Isenberg,Daniel J. Wallace,Ola Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,Sang Cheol Bae,John G. Hanly,Jorge Sanchez-Guerrero,Ann E. Clarke,Cynthia Aranow,Susan Manzi,Murray B. Urowitz,Dafna D. Gladman,Kenneth C. Kalunian,Melissa Costner,Victoria P. Werth,Asad Zoma,Sasha Bernatsky,Guillermo Ruiz-Irastorza,Munther A. Khamashta,Søren Jacobsen,Jill P. Buyon,Peter J. Maddison,Mary Anne Dooley,Ronald F van Vollenhoven,Ellen M. Ginzler,Thomas Stoll,Christine A. Peschken,Joseph L. Jorizzo,Jeffrey P. Callen,S. Sam Lim,Barri J. Fessler,Murat Inanc,Diane L. Kamen,Anisur Rahman,Kristjan Steinsson,Andrew G. Franks,Lisa Sigler,Suhail Hameed,Hong Fang,Ngoc Minh Pham,Robin L. Brey,Michael H. Weisman,Gerald McGwin,Laurence S. Magder +51 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE.
Journal ArticleDOI
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
George Bertsias,John P. A. Ioannidis,John Boletis,Stefano Bombardieri,Ricard Cervera,C. Dostal,J Font,Inge-Magrethe Gilboe,F. Houssiau,Twj Huizinga,David A. Isenberg,Cees G. M. Kallenberg,Munther A. Khamashta,J.C. Piette,Matthias Schneider,Matthias Schneider,Josef S Smolen,Gunnar Sturfelt,Angela Tincani,R. van Vollenhoven,Caroline Gordon,Dimitrios T. Boumpas +21 more
TL;DR: Recommendations for the management of SLE were developed using an evidence-based approach followed by expert consensus with high level of agreement among the experts.
Journal ArticleDOI
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.
Dafna D. Gladman,Murray B. Urowitz,Charles H. Goldsmith,Paul R. Fortin,Ellen M. Ginzler,Caroline Gordon,John G. Hanly,David A. Isenberg,Kenneth C. Kalunian,Ola Nived,Michelle Petri,Jorge Sánchez-Guerrero,M L Snaith,Gunnar Sturfelt +13 more
TL;DR: Physicians from different centers are able to assess patients with SLE in a reproducible way, using the SLEDAI to assess disease activity and the SLICC/ACR Damage Index to assess accumulated damage.
Book
Renal Disease: Classification and Atlas of Glomerular Diseases
TL;DR: An atlas that is really an atlas: an encyclopedic collection of electron micrographs, stained sections (including immunofluorescent stains), and diagrams that primarily illustrate renal diseases and systemic diseases with renal lesions.